John Nardandrea, MD
Family Medicine · Ocala, FLNPI 1871572016
Payments from drug & device makers
Across 1,862 payments — averaging $16,529 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$14.7M
- Eisai Inc.$14M
- Genentech, Inc.$530K
- E.r. Squibb & Sons, L.L.C.$492K
- Novo Nordisk AS$472K
- Amgen$314K
- plus $219K from 26 others
Across 13 payments — averaging $4127.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$54K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 87 | $14,748,497 |
| Eisai Inc. | 1,086 | $14,001,343 |
| Genentech, Inc. | 26 | $530,160 |
| E.r. Squibb & Sons, L.L.C. | 4 | $492,373 |
| Novo Nordisk AS | 372 | $472,284 |
| Amgen(2 entities) | 20 | $314,128 |
| Pfizer | 26 | $177,487 |
| Boehringer Ingelheim | 32 | $24,311 |
| Regeneron | 3 | $12,596 |
| AstraZeneca | 41 | $835 |
| Novo Nordisk | 39 | $761 |
| Amarin Pharma, Inc. | 29 | $523 |
| AbbVie(2 entities) | 20 | $383 |
| GSK | 20 | $368 |
| Lilly USA, LLC | 17 | $342 |
| Johnson & Johnson | 9 | $227 |
| Astellas Pharma US Inc | 7 | $153 |
| Merck | 9 | $149 |
| Medtronic | 1 | $118 |
| Bayer | 1 | $82 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Novartis | 1 | $19 |
| CMP Pharma, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Abbott | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Insulet Corporation | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$30,777,345 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Ocala
- David OliverOcala$4.5M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.